Literature DB >> 18579814

Polygenes, risk prediction, and targeted prevention of breast cancer.

Paul D P Pharoah1, Antonis C Antoniou, Douglas F Easton, Bruce A J Ponder.   

Abstract

BACKGROUND: New developments in the search for susceptibility alleles in complex disorders provide support for the possibility of a polygenic approach to the prevention and treatment of common diseases.
METHODS: We examined the implications, both for individualized disease prevention and for public health policy, of findings concerning the risk of breast cancer that are based on common genetic variation.
RESULTS: Our analysis suggests that the risk profile generated by the known, common, moderate-risk alleles does not provide sufficient discrimination to warrant individualized prevention. However, useful risk stratification may be possible in the context of programs for disease prevention in the general population.
CONCLUSIONS: The clinical use of single, common, low-penetrance genes is limited, but a few susceptibility alleles may distinguish women who are at high risk for breast cancer from those who are at low risk, particularly in the context of population screening. 2008 Massachusetts Medical Society

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579814     DOI: 10.1056/NEJMsa0708739

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  241 in total

Review 1.  The inherited genetics of ovarian and endometrial cancer.

Authors:  Simon A Gayther; Paul D P Pharoah
Journal:  Curr Opin Genet Dev       Date:  2010-04-24       Impact factor: 5.578

2.  Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.

Authors:  Susan L Slager; Christine F Skibola; Maria Chiara Di Bernardo; Lucia Conde; Peter Broderick; Shannon K McDonnell; Lynn R Goldin; Naomi Croft; Amy Holroyd; Shelley Harris; Jacques Riby; Daniel J Serie; Neil E Kay; Timothy G Call; Paige M Bracci; Eran Halperin; Mark C Lanasa; Julie M Cunningham; Jose F Leis; Vicki A Morrison; Logan G Spector; Celine M Vachon; Tait D Shanafelt; Sara S Strom; Nicola J Camp; J Brice Weinberg; Estella Matutes; Neil E Caporaso; Rachel Wade; Martin J S Dyer; Claire Dearden; James R Cerhan; Daniel Catovsky; Richard S Houlston
Journal:  Blood       Date:  2012-06-13       Impact factor: 22.113

3.  Comment on "the predictive capacity of personal genome sequencing".

Authors:  Colin B Begg; Malcolm C Pike
Journal:  Sci Transl Med       Date:  2012-05-23       Impact factor: 17.956

4.  Inclusion of gene-gene and gene-environment interactions unlikely to dramatically improve risk prediction for complex diseases.

Authors:  Hugues Aschard; Jinbo Chen; Marilyn C Cornelis; Lori B Chibnik; Elizabeth W Karlson; Peter Kraft
Journal:  Am J Hum Genet       Date:  2012-05-24       Impact factor: 11.025

5.  Performance of common genetic variants in breast-cancer risk models.

Authors:  Sholom Wacholder; Patricia Hartge; Ross Prentice; Montserrat Garcia-Closas; Heather Spencer Feigelson; W Ryan Diver; Michael J Thun; David G Cox; Susan E Hankinson; Peter Kraft; Bernard Rosner; Christine D Berg; Louise A Brinton; Jolanta Lissowska; Mark E Sherman; Rowan Chlebowski; Charles Kooperberg; Rebecca D Jackson; Dennis W Buckman; Peter Hui; Ruth Pfeiffer; Kevin B Jacobs; Gilles D Thomas; Robert N Hoover; Mitchell H Gail; Stephen J Chanock; David J Hunter
Journal:  N Engl J Med       Date:  2010-03-18       Impact factor: 91.245

6.  Genome-wide association study (GWAS)-identified disease risk alleles do not compromise human longevity.

Authors:  Marian Beekman; Christa Nederstigt; H Eka D Suchiman; Dennis Kremer; Ruud van der Breggen; Nico Lakenberg; Wendimagegn Ghidey Alemayehu; Anton J M de Craen; Rudi G J Westendorp; Dorret I Boomsma; Eco J C de Geus; Jeanine J Houwing-Duistermaat; Bastiaan T Heijmans; P Eline Slagboom
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

7.  Breast cancer susceptibility variants alter risk in familial ovarian cancer.

Authors:  A Latif; H J McBurney; S A Roberts; F Lalloo; A Howell; D G Evans; W G Newman
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

Review 8.  A compendium of genome-wide associations for cancer: critical synopsis and reappraisal.

Authors:  John P A Ioannidis; Peter Castaldi; Evangelos Evangelou
Journal:  J Natl Cancer Inst       Date:  2010-05-26       Impact factor: 13.506

Review 9.  Complex Trait Prediction from Genome Data: Contrasting EBV in Livestock to PRS in Humans: Genomic Prediction.

Authors:  Naomi R Wray; Kathryn E Kemper; Benjamin J Hayes; Michael E Goddard; Peter M Visscher
Journal:  Genetics       Date:  2019-04       Impact factor: 4.562

10.  Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.

Authors:  Merlise A Clyde; Rachel Palmieri Weber; Edwin S Iversen; Elizabeth M Poole; Jennifer A Doherty; Marc T Goodman; Roberta B Ness; Harvey A Risch; Mary Anne Rossing; Kathryn L Terry; Nicolas Wentzensen; Alice S Whittemore; Hoda Anton-Culver; Elisa V Bandera; Andrew Berchuck; Michael E Carney; Daniel W Cramer; Julie M Cunningham; Kara L Cushing-Haugen; Robert P Edwards; Brooke L Fridley; Ellen L Goode; Galina Lurie; Valerie McGuire; Francesmary Modugno; Kirsten B Moysich; Sara H Olson; Celeste Leigh Pearce; Malcolm C Pike; Joseph H Rothstein; Thomas A Sellers; Weiva Sieh; Daniel Stram; Pamela J Thompson; Robert A Vierkant; Kristine G Wicklund; Anna H Wu; Argyrios Ziogas; Shelley S Tworoger; Joellen M Schildkraut
Journal:  Am J Epidemiol       Date:  2016-10-03       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.